Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
CF Acquisition Corp. VI Reminds Stockholders to Vote in Favor of its Business Combination with Rumble, Inc.
-
uniQure to Participate in Upcoming Industry Conferences in September
-
Form 8-K Cantor Fitzgerald Income For: Sep 01
-
IMV Inc. to Present at Two Investor Conferences in September
-
I-Mab (IMAB) PT Lowered to $25 at Cantor Fitzgerald
-
Westrock Coffee Company Announces Closing of Business Combination with Riverview Acquisition Corp. and Entry Into a New Credit Agreement
-
UPDATE: Cantors Starts Mondee Holdings, Inc. (MOND) at Overweight (correction)
-
Form SC 13G SDCL EDGE Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Change Successfully Closes First AAA-Rated Securitization of CDFI Originated Home Loans
-
Form N-PX CANTOR FITZGERALD SUSTAI For: Jun 30
-
Cantor Fitzgerald and BH Acquire Multifamily Asset in Lenexa, Kansas
-
Form SC 13G Black Spade Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G Summit Healthcare Acquis Filed by: CANTOR FITZGERALD SECURITIES
-
4 Penny Stocks Insiders Spent Millions To Buy In August 2022
-
BGC Wins Lawsuit Challenging Purchase of Berkeley Point
-
UNITY Biotechnology (UBX) Prices Upsized 64.3M Share Offering at $0.70/sh
-
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
-
Orchid Island Capital (ORC) Announces 5:1 Reverse Stock Split
-
Orchid Island Capital Announces One-for-five Reverse Stock Split, August 2022 Monthly Dividend and July 31, 2022 RMBS Portfolio Characteristics
-
Form 424B3 Cantor Fitzgerald Income
-
Form SC 13G Finnovate Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Genesis Announces New Leadership Team
-
Sprott Physical Platinum and Palladium Trust Updates Its “At-the-Market” Equity Program
-
UNITY Biotechnology (UBX) to Offer $25M in Common Stock
-
UNITY Biotechnology Announces Proposed Public Offering of Common Stock
-
BTIG Expands Business with Latin America and EMEA Emerging Markets Focus
-
TeraWulf Announces Second Quarter 2022 Results and Financial and Operational Updates
-
Form 13F-NT CANTOR FITZGERALD INVEST For: Jun 30
-
Form 13F-NT Cantor Fitzgerald Europe For: Jun 30
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Jun 30
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Jun 30
-
Form 13F-HR CANTOR FITZGERALD, L. For: Jun 30
-
Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering
-
Cantor Fitzgerald confirms the death of President Anshu Jain
-
Former Deutsche Bank co-CEO Anshu Jain dies
-
5 Penny Stocks To Buy For Under $5
-
Sprott Physical Gold Trust Updates Its “At-The-Market” Equity Program
-
Form SC 13G AfterNext HealthTech Filed by: CANTOR FITZGERALD SECURITIES
-
Form 10-Q Cantor Fitzgerald Income For: Jun 30
-
Rumble and CFVI Announce Effectiveness of S-4 Registration Statement
-
Stoa Announces Additional $100 Million Raised to Help Real Estate Investors Flip Homes Faster
-
Critical Elements complete Positive Engineering Study for a Lithium Hydroxide Monohydrate Plant
-
Westwater Resources, Inc. Announces Results for Second Quarter Ended June 30, 2022
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
-
Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
-
Aytu BioScience (AYTU) Prices Public Offering of Common Stock, Warrants
-
Aytu BioPharma Announces Pricing of Public Offering
-
Heron Therapeutics (HRTX) Announces 16.13M Share Private Placement at $3.10/sh
-
Heron Therapeutics Announces $76.5 Million Private Placement Financing

